AzTrials
AzTrials

Feedback, PsychologicalNFPESNCT02477722

Neurofeedback Prevention For Early Stress Related Adversity

A study testing EFP-NF in people with Feedback, Psychological and Stress Disorders, Post-Traumatic, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Exposure to life threatening, traumatic and stress inducing events in general is an inevitable part of military combat service . Among individuals exposed to a traumatic event, approximately 85-90 % will develop a stress response from which they will recover without need for any medical intervention whatsoever. Read more about this study

Who is it for?
Ages 18 to 40 years
What is being tested?
EFP-NF
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteIsrael
Study dates
Apr 2016to Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Exposure to traumatic event in the past 14 days. Standard criteria for inclusion in medical MRI scans, according to the procedures set forth at MRI Medical Center in Tel - Aviv Sourasky will be applied to all participants.

Who cannot join

  • Standard criteria for exclusion in medical MRI scans, according to the procedures set forth at MRI Medical Center in Tel - Aviv Sourasky will be applied to all participants and in accordance with the "metal form". For example, metal that cannot be removed, Orthodontal accessories connected to ones teeth, or current systemic diseases (including chronic diseases).

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Whol Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center

    Tel Aviv

Other trials in Israel

About this study

Official title: Neurofeedback Preventive Intervention for PTSD: a Method to Strengthen Mental and Emotional Resilience

Exposure to life threatening, traumatic and stress inducing events in general is an inevitable part of military combat service . Among individuals exposed to a traumatic event, approximately 85-90 % will develop a stress response from which they will recover without need for any medical intervention whatsoever. However, roughly 10-15 % will continue to suffer from post-traumatic symptoms along with depression or anxiety disorders1, . The prominent symptoms of post - traumatic stress disorder (PTSD), consists of reliving the event via invasive and painful memories that include: images, thoughts or feelings, night terrors, and extreme emotional distress that arise when exposure to external or internal cues similar to or symbolizing aspects of the traumatic event. Following this distress, behavioral avoidance of situations that trigger unpleasant memories may develop. Such mental stress may lead to avoidance of social situations and hinder normal daily functioning in a variety of contexts2. The question arises as to what distinguishes between those who are exposed to a traumatic event and recover spontaneously and those who fail to resume daily life and develop PTSD. Attempts to find personality and environmental risk factors for the development of PTSD have yet to yield any unequivocal conclusions. This has lead the scientific community to look for neuro-physical risk factors as well . Furthermore, evidence that early diagnosis and treatment of the disorder helps reduce the severity of post-trauma symptoms -stresses the need for the accurate localization of neurological risk factors and new immediate and/or preventative interventions. The aim of the present project is to develop a brain oriented training method for early preventive interventions of PTSD.

Read the detailed description

The most significant disadvantage of the current EEG-NF method is the low spatial resolution of the EEG, which does not allow for the localization of site activity within deep brain regions known to be associated with the development of PTSD, such as the amygdala, the hippocampus, and the mPFC. The aim of the present project is to overcome this drawback by integrating EEG and fMRI imaging methods, such that the patient will receive real-time feedback regarding the activation of emotional target areas located deep within the brain. FMRI is based on the measurement of metabolic changes following electrical activity in the brain, thus non-invasively representing the neuronal activity of various brain regions when performing emotional and/or cognitive tasks. fMRI has high spatial resolution, and in contrast to EEG - it allows for the localization of regions deep within the brain, such as those related to trauma responses within the limbic system and prefrontal cortex. Recently, real-time fMRI (rt fMRI) has been used to train subjects to modulate activity within deep brain regions , . Some studies have even shown that subjects can be trained to regulate activity within a network of regions including the mPFC and limbic regions, resulting in a positive effect on patients suffering from chronic pain and depression . Moreover, it has also been found that via real-time fMRI feedback subjects can be trained to regulate activity within networks that have been linked to emotional regulation; a skill critical for dealing with traumatic events . The major disadvantage of this method is that fMRI tests are expensive and inconvenient for the patient, and the MRI machine required for this method are stationary and not easily accessible.

To combine the advantages of both methods the investigators performed simultaneous testing of both EEG and fMRI. Using special algorithms, with high reliability, the investigators studied the electrical signals that represent activity related to emotional regulation within deep brain regions . This combination allowed for a significant improvement in the spatial resolution of the EEG device and added significant temporal information taken from the fMRI signal. The combined recording of EEG and fMRI with advanced computational methods, such as cross correlation and machine learning, provide significant improvement in the attribution of EEG signal localization, which until now could not be achieved with adequate reliability. In other words, the EEG pattern of activity reliably represents activation of deep limbic regions providing an "electrical fingerprint" (EFP) of these areas.

Accordingly, the investigators developed an innovative treatment protocol in which subjects are asked to control either visual or auditory stimuli, determined by feedback from the brain, based on the extent of the EFP . In a pilot study on a group of civilians the investigators showed that subjects successfully learned to modify their electrical brain signal based on the EFP . In an additional study, simultaneous recordings of EEG and fMRI showed that success was indeed related to changes in activity within deep brain regions involved in emotional regulation; such as the mPFC and hippocampus. Furthermore, our results indicate that following training to volitionally regulate the EFP via EEG-NF, participants exhibited improved emotion regulation .

Rationale for current study:

Based on the EFP model and the NF literature in the treatment of PTSD this study aims to examine the efficiency of an fMRI-guided-EEG-protocol for self-regulation through NF for reducing stress vulnerability.

The study will assign two groups:

experimental group: EFP neurofeedback control groups: Sham neurofeedback In order to assess the efficiency of the NF protocol as a preventative intervention for PTSD, the investigators plan to compare this treatment outcomes to those of a placebo sham protocol.

Primary objective:

Examine the efficiency of NF in reducing stress vulnerability.

Secondary objective:

Examine the efficiency of amygdala targeted Neurofeedback (NF) in reducing stress symptoms among individuals who were recently exposed to a traumatic event. .

Study design:

Randomized parallel design, with 2 groups: EFP-NF (n=35), Sham-NF (n=35)

Participant selection:

The study will involve 40 participants with PTSD symptoms between the ages of 18-40, who will be divided randomly into 2 groups (experimental group, control group).

Number of participants:

The study will involve 70 individuals.

Recruitment process:

Participants will be recruited from the ER and trauma clinic at TASMC. The hospital will provide our research team with daily lists of the individuals who arrived at the ER over the past 24 hours, screened for possible trauma related incidents. Our team will then contact the potential subjects over the phone and will request informed consent to conduct a phone interview to assess the presence of acute stress symptoms. A brief description of the study will be provided. If the individual agrees and is found suitable for further participation they will be invited to the trauma clinic at TASMC where a trained clinical psychologist will conduct a comprehensive PTSD evaluation. The trauma clinic at TASMC will also refer suitable patients from within their database for participation in our study. All subjects referred by the trauma clinic will undergo identical procedures for obtaining informed consent and subsequent clinical evaluation as those described above.

Intervention arms:

The study will include 2 groups. The experimental group will receive EEG-NF sessions targeted on the amygdalae and the control group will Sham-NF.

Brain area/s of interest:

The regions of interest will include the limbic system and more specifically the Amygdala, hippocampus ventral striatum, as well as cortical areas associated with emotional regulation (such as dorso-lateral PFC and dorso and ventro-medial PFC cingulated cortex and insula).

Study procedures:

Pre treatment phase Day 1 Participants will undergo a psychiatric evaluation (using SCID), and medication monitoring. Participants will also be asked to fill in demographic and psychological questionnaires assessing emotion regulation abilities (ERQ), state anxiety and traits (STAI), and questionnaires measuring symptoms of stress, anxiety and depression (CAPS, PCL, BDI).

Day 2 All Participants will undergo a brain-imaging scan to characterize brain network responses associated with emotional arousal and regulation. Participants will be scanned for functional and structural MRI which will include ROI localizer for the NF, resting state, emotional conflict task, facial recognition task reward task and DTI.

The research staff will explain the course of the MRI testing to the participant, and will enter with the subject into the mock simulator to verify that he is lying on his back properly and feels comfortable. During testing the patient will be presented with visual and auditory stimuli, as well as short video clips. Auditory presentation: stimuli will be heard via MRI-compatible headphones. Visual displays: the subject will view the stimuli through a mirror and projected onto a screen in the magnet room. In between sessions the patient will be given time to rest. Participants will be asked to avoid moving as much as possible during the scans.

The total duration of testing, from subject arrival to departure, will take approximately 90-180 minutes (20-30 minutes to fill out forms and undergo training, 30 minutes for explanations and a break, and 60 minutes of imaging). Participants will remain in the MRI for about 60 minutes, and under no circumstances will remain longer than 90 minutes.

Training phase The duration of the training phase will be 4 weeks. At this point participants will be randomly assigned to either the EFP-NF or T/A-NF groups. Both the EFP-NF and the T/A-NF groups will receive 1-2 sessions per week for a total of 6 sessions.

During training sessions, participants will train to develop skills for regulating brain activity using auditory or visual feedback. Each session will last an hour, including EEG Cap placement and filling state questionnaires. The participant will be seated comfortably in front of a computer screen. A staff member will explain the goal of the meeting to the participant, introduce the equipment to be used, and describe the course of the meeting. Following the above explanations, the staff member will place the EEG cap on the participant's head and will ensure that the participant feels comfortable. The EEG - Neurofeedback practice will consist of five-minute segments repeated for up to 30 minutes. During each practice segment the participant will be asked to modify any visual or auditory media that provides feedback on the degree of successful brain training. For example, during visual feedback the participants will be asked to lower the speed of a skateboard presented on the computer screen or alternatively, during auditory feedback to reduce the level of music audible through headphones placed on their ears. After every two practice segments, the duration of each practice will increase such that the two first steps will be very short (about 5 minutes each) and the last two the longest (about 10 minutes each); a total of six steps every trial over a total of approximately 45 minutes

Post treatment phase This phase will take place 3-5 days after the end of the training phase. Day 1

  • Participants will undergo a second psychological evaluation (CAPS).
  • Participants will complete the same questionnaires as in the pre treatment phase (BDI, ERQ, STAI, PCL).

Day 2 • All Participants will be scanned for functional and structural MRI which will include ROI localizer, resting state, DTI.

Follow-up phase Day 1-5

  • All participants will receive 2 maintenance sessions (EFP-NF or T/A-NF)

Day 6

  • Participants will undergo a third psychological evaluation (CAPS).
  • Participants will complete the same questionnaires as in the previous phases (BDI, ERQ, STAI, PCL).

Data collection:

Researchers will assist participants filling in the electronic questionnaires and will conduct the non electronic ones (these would be later transcribed to excel sheets by research assistants).

Researchers will run the MRI scans and the NF sessions (all the rt-fMRI NF and some of the EFP-NF), together with two to five research assistants. The contact with the participants will be by E-mail and phone. The research assistants will monitor participation. The participants will receive a reminder (by phone and or email) one day prior to each session.

Being tested
EFP-NF, Sham
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EFP-NFOther

  • ShamOther

Study groups in NCT02477722
Study groupRoleWhat they receive
EFP-NFExperimentalSubjects are asked to change their brain activity in response to feedback they receive from the brain itself, mediated via various visual or auditory stimuli.
Receives: Other: EFP-NF
Sham-NFSham comparatorPlacebo
Receives: Other: Sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Psychiatric Evaluation of PTSD Symptoms

    Measured: Days 1-7 and 6 months after training

Secondary outcomes (7)
  1. fMRI Scan as a measure of change in amygdala reactivity

    Measured: Days 1-7 and 6 months after training

  2. Change in Emotion Regulation Questionnaire (ERQ) as a measure of change in cognitive coping strategies

    Measured: Days 1-7 and 6 months after training

  3. State/Trait Anxiety Inventory (STAI) as a measure of change in state & trait anxiety

    Measured: Days 1-7 and 6 months after training

  4. Beck Depression Inventory (BDI-II) as a measure of change in clinical depression

    Measured: Days 1-7 and 6 months after training

  5. Debriefing interview questionnaire as a measure of general experience of the process and adverse effects

    Measured: 6 months after training

  6. PCL as a measure of change in PTSD symptoms

    Measured: Days 1-7 and 6 months after training

  7. Emotional conflict task as a measure of change in facial recognition measuring emotional regulation

    Measured: Days 1-7 and 6 months after training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2015 (estimated)
  2. Study startApr 2016
  3. Primary completionNov 2018 (estimated)
  4. Study completionJun 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02477722
Sponsor's protocol ID
0616-14-TLV
Acronym
NFPES
Status last verified
Mar 2018
First submitted
31 May 2015
Last updated
6 Mar 2018
Results posted
No
Data monitoring committee
No

Publications

  • Caria A, Veit R, Sitaram R, Lotze M, Weiskopf N, Grodd W, Birbaumer N. Regulation of anterior insular cortex activity using real-time fMRI. Neuroimage. 2007 Apr 15;35(3):1238-46. doi: 10.1016/j.neuroimage.2007.01.018. Epub 2007 Jan 31.

    PubMed 17336094
  • deCharms RC, Christoff K, Glover GH, Pauly JM, Whitfield S, Gabrieli JD. Learned regulation of spatially localized brain activation using real-time fMRI. Neuroimage. 2004 Jan;21(1):436-43. doi: 10.1016/j.neuroimage.2003.08.041.

    PubMed 14741680
  • deCharms RC, Maeda F, Glover GH, Ludlow D, Pauly JM, Soneji D, Gabrieli JD, Mackey SC. Control over brain activation and pain learned by using real-time functional MRI. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18626-31. doi: 10.1073/pnas.0505210102. Epub 2005 Dec 13.

    PubMed 16352728
  • Linden, D. & Lancaster, T. (2011). Functional magnetic resonance imaging (fMRI) - based neurofeedback as a new treatment tool for depression. European Psychiatry, 26(1), 937-946.

  • Johnston SJ, Boehm SG, Healy D, Goebel R, Linden DE. Neurofeedback: A promising tool for the self-regulation of emotion networks. Neuroimage. 2010 Jan 1;49(1):1066-72. doi: 10.1016/j.neuroimage.2009.07.056. Epub 2009 Jul 29.

    PubMed 19646532
  • Meir-Hasson Y, Kinreich S, Podlipsky I, Hendler T, Intrator N. An EEG Finger-Print of fMRI deep regional activation. Neuroimage. 2014 Nov 15;102 Pt 1:128-41. doi: 10.1016/j.neuroimage.2013.11.004. Epub 2013 Nov 15.

    PubMed 24246494
  • Cavazza, M. et al., Towards emotional regulation through neurofeedback, in Proceedings of the 5th Augmented Human International Conference (ACM, March, 2014), p. 42.

  • Meir-Hasson, Y. et al., A Common amygdala EEG Finger-Print for self-regulation training, (Submitted). Journal of Neuroscience Methods.

  • Keynan, J.N., et al.,. Reaching the unreachable: online-monitoring and guided regulation of amygdala activity using spatially enriched EEG. (In Preparation).

Questions about this trial

What is this clinical trial studying?

A study testing EFP-NF in people with Feedback, Psychological and Stress Disorders, Post-Traumatic, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Psychiatric Evaluation of PTSD Symptoms (time frame: Days 1-7 and 6 months after training). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02477722, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in